ITIC2 Trial - Topical Imiquimod versus Conization to Treat Cervical Intraepithelial Neoplasia: Randomised Controlled, Non-inferiority Trial
Phase of Trial: Phase III
Latest Information Update: 07 Nov 2016
At a glance
- Drugs Imiquimod (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- 30 Oct 2016 Status changed from recruiting to discontinued.
- 02 Mar 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2012-004518-32).
- 13 Feb 2013 Status changed from not yet recruiting to recruiting as reported European Clinical Trials Database.